Acryl
Financials
Valuation Metrics
Acryl's Market Cap is ₩1320B. Ranked #1058 of 2,436 in KR market (top 43%), #540 of 1,649 on KOSDAQ (top 33%), #32 of 160 in Software & Services (top 20%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 132.02B KRW | KR#1,058/2,436 Sec#32/160 |
| Revenue | 13.31B KRW | KR#2,242/2,436 Sec#143/160 |
| Net Income | -2.81B KRW | KR—/2,436 Sec—/160 |
| Total Assets | 50.94B KRW | KR#2,186/2,436 Sec#119/160 |
| Net Assets | 43.75B KRW | KR#1,965/2,436 Sec#101/160 |
| Value | ||
| P/B | 3.02x | KR#2,116/2,436 Sec#139/160 |
| P/S | 9.92x | KR#2,267/2,436 Sec#153/160 |
| FCF Yield | -4.44% | KR—/2,436 Sec—/160 |
| Profitability | ||
| ROE | -6.42% | KR#1,789/2,436 Sec#113/160 |
| ROA | -5.51% | KR#1,916/2,436 Sec#120/160 |
| Op. Margin | -16.93% | KR#2,087/2,436 Sec#133/160 |
| Financial Health | ||
| Debt Ratio | 116.43% | KR#574/2,436 Sec#49/160 |
| FCF | -5.86B KRW | KR#1,538/2,436 Sec#116/160 |
| Cash | 41.39B KRW | KR#845/2,436 Sec#27/160 |
| Current Ratio | 7.79x | KR#161/2,436 Sec#15/160 |
| Performance | ||
| 1M Return | -4.31% | KR#1,328/2,436 Sec#105/160 |
| From 52W High | -78.65% | KR#2,337/2,436 Sec#154/160 |
| 1Y MDD | -80.30% | KR#2,303/2,436 Sec#147/160 |
| Trading | ||
| Volume | 80,855 shares | KR#1,060/2,436 Sec#64/160 |
| Foreign Own. | 2.85% | KR—/2,436 Sec—/160 |
| Per Share | ||
| EPS | -478 KRW | KR—/2,436 Sec—/160 |
| BPS | 5,375 KRW | KR#1,388/2,436 Sec#55/160 |
Company Info
Acryl, established in 2011 and headquartered in Gangnam-gu, Seoul Metropolitan City, is an AI eXperience (AX) infrastructure specialist. The company supports the entire process from AI service construction to infrastructure operation, leveraging AI infrastructure technology. It develops NLP-related deep learning original technology for high-performance emotional recognition and creates software services to effectively deliver artificial intelligence. Its product lines include the integrated artificial intelligence platform 'Jonathan' and the medical-specialized artificial intelligence platform 'Nadia'.